Working with MAC can be a pain!
Citylabs Lounge is a monthly networking event for clinicians, academics, healthcare businesses and all others who are interested in current topical issues and challenges in healthcare and life science sectors. Located in the heart of Manchester’s Innovation District, these events provide a valuable opportunity for people to engage with prospective clients and customers, and have their say on the issues discussed.
In February, we will hear from MAC Clinical Research - the UK's largest neuroscience research company. MAC Clinical Research are committed to the recruitment and conduction of clinical trials through its own Dedicated Research Sites and staff.
MAC perform clinical trials in a variety of therapeutic areas such as Dementia, arthritis, dermatology and pain for the international Pharmaceutical Industry. Having recently inaugurated the first completely new Early Phase Drug Research Unit in the UK for a decade (right here in Manchester), MAC will be at Citylabs Lounge to tell us about their latest developments. Not to mention, you will also have the chance to take part in pain testing yourself
After a brief introduction from Dr Peter Dewland, Senior Director of Early Phase Research, we will hear from our “PAIN” expert, Dr John Connell, who will tell us about a variety of methods we have for testing pain both in Healthy volunteers and in patients with painful conditions. Anyone interested in Clinical Research will benefit from attending.
About the speakers:
Dr John Connell
Chief Research and Development Officer
Dr John Connell completed his PhD at the University of Manchester in 1996 and has over 30 years experience in Clinical Research. Dr Connell worked as Global Vice President of Pharmacodynamics for ICON Development Solutions for 18 years and contributed to over 200 studies at ICON’s UK and US clinics, covering a wide range of therapeutic indications. In 2014 he joined MAC Clinical Research as Chief Research and Development Officer where he works closely with the Translational Research Department, supporting their pharmacodynamic work in both healthy volunteers and patient populations.
Dr Peter Dewland
Senior Director of Early Phase Research
Dr Peter Dewland started the first UK national training course for members of Research Ethics Committees. Nowadays there are more early phase studies being done in patient groups, so along with others he recently set up a new Phase I unit at the MRI and is the only person to have gained MHRA accreditation for three separate UK units. He recently headed up Translational Medicine and Clinical Pharmacology for Daiichi Sankyo in the UK and is now Senior Director of Early Phase Research at MAC Clinical Research in Manchester UK.